CD40 and myeloid sarcoma: B cells of MS patients exhibited an abnormal cytokine profile, involving significantly higher expressions of LT and TNFα upon ‘dual BCR+CD40 stimulation’, and significantly lower expression of IL-10 upon ‘CD40 stimulation’, as compared to HS B cells (Figure 1A), confirming our previously reported findings [5], [6].